Order for five Arcam Q10 systems from Beijing AK Medical in China


Arcam AB, listed on NASDAQ Stockholm, has received an order for five Arcam Q10
systems from Beijing AK Medical, a present customer in China. The systems will
be used for volume production of orthopedic implants.
Beijing AK Medical, established in 2003, is in the orthopedic industry
specialized in researching, developing, manufacturing and sale of artificial
joint prosthesis and its complete set of surgical instruments. Beijing AK
Medical is a customer to Arcam since 2010 and announced in August that they
received formal approval from the Chinese State Food and Drug Administration
(CFDA) for EBM manufactured implants. This was the first CFDA marketing approval
for an additively manufactured orthopedic implant.

"We are happy to present this order from Beijing AK Medical, a customer since
long and a leading Chinese Implant manufacturer, driving the adaptation to
Additive Manufacturing in China. This order also shows that the implant industry
in China is now moving to volume production of medical implants with our EBM
technology”,
says Magnus René, CEO of Arcam.

“We are excited to move into volume production with the EBM technology. Having
worked with Arcam since 2010 we are now ramping up our activities, following the
recent approval by the CFDA”, says Mr Li Zhi Jiang, CEO of Beijing AK Medical.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail:
magnus.rene@arcam.com
Arcam Group provides cost-efficient Additive Manufacturing solutions for
production of metal components. Arcam’s Electron Beam Melting (EBM®) technology
offers design freedom combined with excellent material properties and high
productivity. Arcam is, through its solution orientation and comprehensive
product offering, an innovative partner for advanced manufacturing, primarily
for the aerospace and medical industries. Arcam offers EBM systems through Arcam
AB in Sweden, powder metals through AP&C in Canada and implant contract
manufacturing through DiSanto in the U.S.The company is listed on Nasdaq
Stockholm and the Head Office is located in Mölndal, Sweden.

________________________________________________________________________________
_ 
_______

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00
• www.arcam.com

Attachments

09234397.pdf